← Back to Search

Aftercare Treatment for Obsessive-Compulsive Disorder

N/A

Waitlist Available

Led By Carolyn Rodriguez, MD, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 14 weeks

Awards & highlights

Study Summary

This trial is for OCD patients who have completed a different study protocol and are now looking for aftercare treatment options.

Who is the study for?

This trial is for adults with Obsessive Compulsive Disorder (OCD) who have finished a previous study at the Rodriguez Lab. They must understand the risks and benefits of this study, be able to consent, and speak English. It's not open to anyone under 18 or those currently having thoughts of suicide.Check my eligibility

What is being tested?

The trial offers ongoing treatment options for OCD through pharmacotherapy (medication) and psychotherapy (counseling). It's designed for patients from prior studies at the Rodriguez Lab to continue receiving care and support.See study design

What are the potential side effects?

While specific side effects are not listed here, generally, medications can include nausea, headache, sleep disturbances or mood changes; psychotherapy might bring up uncomfortable emotions but is usually safe.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 14 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 14 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 14 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Improvement in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)

Trial Design

2Treatment groups

Active Control

Group I: PharmacotherapyActive Control1 Intervention

Participants will receive pharmacotherapy by a psychiatrist

Group II: PsychotherapyActive Control1 Intervention

Participants will receive evidenced based psychotherapy by a trained psychologist

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,386 Previous Clinical Trials

17,333,808 Total Patients Enrolled

15 Trials studying Obsessive-Compulsive Disorder

1,203 Patients Enrolled for Obsessive-Compulsive Disorder

Carolyn Rodriguez, MD, PhDPrincipal Investigator - Assistant Professor, Stanford University

Stanford University

5 Previous Clinical Trials

68 Total Patients Enrolled

2 Trials studying Obsessive-Compulsive Disorder

52 Patients Enrolled for Obsessive-Compulsive Disorder

Media Library

Pharmacotherapy Clinical Trial Eligibility Overview. Trial Name: NCT03511534 — N/A

Obsessive-Compulsive Disorder Research Study Groups: Pharmacotherapy, Psychotherapy

Obsessive-Compulsive Disorder Clinical Trial 2023: Pharmacotherapy Highlights & Side Effects. Trial Name: NCT03511534 — N/A

Pharmacotherapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03511534 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this experiment still ongoing?

"Affirmative. The records posted on clinicaltrials.gov reveal that this research project, which was initially established in June 2017, is actively enrolling new participants. At present, 200 patients need to be recruited from a single site."

Answered by AI

How many participants have been accepted into this clinical investigation?

"Yes, the information on clinicaltrials.gov denotes that this medical trial is actively enrolling. The project was first posted on June 23rd 2017 and most recently revised on May 13th 2020. This study seeks to recruit 200 participants from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder

Carolyn Rodriguez 2017. "Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03511534.

All > Ocd